Brief: BioRestorative Therapies Presents Preliminary Clinical Data of BRTX-100
Feb 5 (Reuters) - BioRestorative Therapies Inc BRTX.O :
* BIORESTORATIVE THERAPIES PRESENTS PRELIMINARY CLINICAL
DATA FROM
PHASE 2 STUDY OF BRTX-100 IN CHRONIC LUMBAR DISC DISEASE
* BIORESTORATIVE THERAPIES INC - PRELIMINARY DATA INCLUDES
26 AND
52-WEEK FOLLOW-UP END POINTS AS PART OF ONGOING PHASE 2 TRIAL
Source text for Eikon: ID:nGNXbxzmJr
Further company coverage: BRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM